Pomegranate in human health: An overview

Bioactive Foods in Promoting Health

Volumn , Issue , 2010, Pages 551-563

  Faria, Ana ^a   Calhau, Conceição ^b  

^a University of Porto   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

Antioxidant; Cancer; Ellagitannin; Inflammation; Pomegranate; Punicalagin

Indexed keywords

EID: 80054010018     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374628-3.00036-0     Document Type: Chapter

References (94)

1. Lansky E.P., Newman R.A. Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer. Journal of Ethnopharmacology 2007, 109:177-206.
2. Mahdihassan S. Outline of the beginnings of alchemy and its antecedents. American Journal Chinese Medicals 1984, 12:32-42.
3. Naqvi S.A.H., Khan M.S.Y., Vohora S.B. Anti-bacterial anti-fungal and anthelmintic investigations on Indian medicinal plants. Fitoterapia 1991, 62:221-228.
4. Caceres A., Giron L.M., Alvarado S.R., Torres M.F. Screening of antimicrobial activity of plants popularly used in Guatemala for the treatment of dermatomucosal diseases. Journal of Ethnopharmacology 1987, 20:223-237.
5. Curry, S. C. (2004). Breast enhancement system. USA.
6. Mixture of vegetable oil for use in cleansing cosmetics e.g. Soap and shampoo, contains extract obtained from varieties of pomegranate seeds such as black large seeded shiraz from Iran and malas shirin. PERUSHAZAKURO YAKUHIN KK (PERU-Non-standard). Japanese patent no. JP2004083544-A.
7. Cosmetics for suppressing ageing effect contain ageing inhibitor which consists of essence of plant seed of pomegranate. Pola Chem Ind. Inc. (Pokk). Japanese patent no. JP2000143491-A.
8. Gil M.I., Tomas-Barberan F.A., Hess-Pierce B., Holcroft D.M., Kader A.A. Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. Journal of Agricultural and Food Chemistry 2000, 48:4581-4589.
9. Kulkarni A.P., Mahal H.S., Kapoor S., Aradhya S.M. In vitro studies on the binding, antioxidant, and cytotoxic actions of punicalagin. Journal of Agricultural and Food Chemistry 2007, 55:1491-1500.
10. Singh R.P., Chidambara Murthy K.N., Jayaprakasha G.K. Studies on the antioxidant activity of pomegranate (Punica granatum) peel and seed extracts using in vitro models. Journal of Agricultural and Food Chemistry 2002, 50:81-86.
11. Guo S., Deng Q., Xiao J., Xie B., Sun Z. Evaluation of antioxidant activity and preventing DNA damage effect of pomegranate extracts by chemiluminescence method. Journal of Agricultural and Food Chemistry 2007, 55:3134-3140.
12. Kaufman M., Wiesman Z. Pomegranate oil analysis with emphasis on maldi-tof/ms triacylglycerol fingerprinting. Journal of Agricultural and Food Chemistry 2007, 55:10405-10413.
13. Tsuyuki H., Itoh S., Nakatsukasa Y. Studies on the lipids in pomegranate punica-granatum-var-nana seeds. Bulletin of the College of Agriculture and Veterinary Medicine Nihon University 1981, 6:141-148.
14. Li Y.F., Guo C.J., Yang J.J., Wei J.Y., Xu J., Cheng S. Evaluation of antioxidant properties of pomegranate peel extract in comparison with pomegranate pulp extract. Food Chemistry 2006, 96:254-260.
15. Okonogi S., Duangrat C., Anuchpreeda S., Tachakittirungrod S., Chowwanapoonpohn S. Comparison of antioxidant capacities and cytotoxicities of certain fruit peels. Food Chemistry 2007, 103:839-846.
16. Mirdehghan S.H., Rahemi M. Seasonal changes of mineral nutrients and phenolics in pomegranate (punica granatum l.) fruit. Scientia Horticulturae 2007, 111:120-127.
17. Halliwell B. Antioxidant defence mechanisms: From the beginning to the end (of the beginning). Free Radical Research 1999, 31:261-272.
18. Halliwell B., Gutteridge J. Free radicals, other reactive species and disease. free radicals in biology and medicine 2000, Oxford Scientific Publications, Oxford, pp. 617, 783.
19. Valko M., Izakovic M., Mazur M., Rhodes C.J., Telser J. Role of oxygen radicals in DNA damage and cancer incidence. Molecular and Cellular Biochemistry 2004, 266:37-56.
20. Kehrer J.P. Free radicals as mediators of tissue injury and disease. Critical Reviews in Toxicology 1993, 23:21-48.
21. Storz P. Reactive oxygen species in tumor progression. Frontiers in Bioscience 2005, 10:1881-1896.
22. Masella R., Di Benedetto R., Vari R., Filesi C., Giovannini C. Novel mechanisms of natural antioxidant compounds in biological systems: Involvement of glutathione and glutathione-related enzymes. Journal of Nutritional Biochemistry 2005, 16:577-586.
23. Benzie I.F. Evolution of dietary antioxidants. Comparative Biochemistry and Physiology Part A: Molecular and Integrative Physiology 2003, 136:113-126.
24. Ross J.A., Kasum C.M. Dietary flavonoids: Bioavailability, metabolic effects, and safety. Annual Review of Nutrition 2002, 22:19-34.
25. Heim K.E., Tagliaferro A.R., Bobilya D.J. Flavonoid antioxidants: Chemistry, metabolism and structure-activity relationships. Journal of Nutritional Biochemistry 2002, 13:572-584.
26. Rice-Evans C.A., Miller N.J., Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radical Biology and Medicine 1996, 20:933-956.
27. Tapiero H., Tew K.D., Ba G.N., Mathe G. Polyphenols: Do they play a role in the prevention of human pathologies?. Biomedicine and pharmacotherapy 2002, 56:200-207.
28. Williams R.J., Spencer J.P., Rice-Evans C. Flavonoids: Antioxidants or signalling molecules?. Free Radical Biology and Medicine 2004, 36:838-849.
29. Aviram M., Dornfeld L., Rosenblat M., Volkova N., Kaplan M., Coleman R., Hayek T., Presser D., Fuhrman B. Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: Studies in humans and in atherosclerotic apolipoprotein E-deficient mice. American Journal of Clinical Nutrition 2000, 71:1062-1076.
30. Malik A., Afaq F., Sarfaraz S., Adhami V.M., Syed D.N., Mukhtar H. Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer. Proceedings of the National Academy of Sciences of the USA 2005, 102:14813-14818.
31. Martin I., Grotewiel M.S. Oxidative damage and age-related functional declines. Mechanisms of Ageing and Development 2006, 127:411-423.
32. Terman A., Brunk U.T. Oxidative stress, accumulation of biological 'garbage', and aging. Antioxidants and Redox Signaling 2006, 8:197-204.
33. Aviram M., Dornfeld L. Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure. Atherosclerosis 2001, 158:195-198.
34. Kaplan M., Hayek T., Raz A., Coleman R., Dornfeld L., Vaya J., Aviram M. Pomegranate juice supplementation to atherosclerotic mice reduces macrophage lipid peroxidation, cellular cholesterol accumulation and development of atherosclerosis. Journal of Nutrition 2001, 131:2082-2089.
35. Seeram N.P., Adams L.S., Henning S.M., Niu Y., Zhang Y., Nair M.G., Heber D. In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice. Journal of Nutritional Biochemistry 2005, 16:360-367.
36. Rozenberg O., Howell A., Aviram M. Pomegranate juice sugar fraction reduces macrophage oxidative state, whereas white grape juice sugar fraction increases it. Atherosclerosis 2006, 188:68-76.
37. Adams L.S., Seeram N.P., Aggarwal B.B., Takada Y., Sand D., Heber D. Pomegranate juice, total pomegranate ellagitannins, and punicalagin suppress inflammatory cell signaling in colon cancer cells. Journal of Agricultural and Food Chemistry 2006, 54:980-985.
38. Lei F., Zhang X.N., Wang W., Xing D.M., Xie W.D., Su H., Du L.J. Evidence of anti-obesity effects of the pomegranate leaf extract in high-fat diet induced obese mice. International Journal of Obesity (2005) 2007, 31:1023-1029.
39. Li Y., Qi Y., Huang T.H., Yamahara J., Roufogalis B.D. Pomegranate flower: A unique traditional antidiabetic medicine with dual PPAR-alpha/gamma activator properties. Diabetes Obesity and Metabolis 2008, 10:10-17.
40. Huang T.H., Peng G., Kota B.P., Li G.Q., Yamahara J., Roufogalis B.D., Li Y. Pomegranate flower improves cardiac lipid metabolism in a diabetic rat model: Role of lowering circulating lipids. British Journal of Pharmacology 2005, 145:767-774.
41. Kaur G., Jabbar Z., Athar M., Alam M.S. Punica granatum (pomegranate) flower extract possesses potent antioxidant activity and abrogates Fe-NTA induced hepatotoxicity in mice. Food and Chemical Toxicology 2006, 44:984-993.
42. Schubert S.Y., Lansky E.P., Neeman I. Antioxidant and eicosanoid enzyme inhibition properties of pomegranate seed oil and fermented juice flavonoids. Journal of Ethnopharmacology 1999, 66:11-17.
43. de Nigris F., Balestrieri M.L., Williams-Ignarro S., D'Armiento F.P., Fiorito C., Ignarro L.J., Napoli C. The influence of pomegranate fruit extract in comparison to regular pomegranate juice and seed oil on nitric oxide and arterial function in obese Zucker rats. Nitric Oxide 2007, 17:50-54.
44. Aslam M.N., Lansky E.P., Varani J. Pomegranate as a cosmeceutical source: Pomegranate fractions promote proliferation and procollagen synthesis and inhibit matrix metalloproteinase-1 production in human skin cells. Journal of Ethnopharmacology 2006, 103:311-318.
45. Kohno H., Suzuki R., Yasui Y., Hosokawa M., Miyashita K., Tanaka T. Pomegranate seed oil rich in conjugated linolenic acid suppresses chemically induced colon carcinogenesis in rats. Cancer Science 2004, 95:481-486.
46. Yamasaki M., Kitagawa T., Koyanagi N., Chujo H., Maeda H., Kohno-Murase J., Imamura J., Tachibana H., Yamada K. Dietary effect of pomegranate seed oil on immune function and lipid metabolism in mice. Nutrition 2006, 22:54-59.
47. Aviram M., Volkova N., Coleman R., Dreher M., Reddy M.K., Ferreira D., Rosenblat M. Pomegranate phenolics from the peels, arils, and flowers are antiatherogenic: Studies in vivo in atherosclerotic apolipoprotein E-deficient (E 0) mice and in vitro in cultured macrophages and lipoproteins. Journal of Agricultural and Food Chemistry 2008, 56:1148-1157.
48. Guo C.J., Yang J.J., Wei J.Y., Li Y.F., Xu J., Jiang Y.G. Antioxidant activities of peel, pulp and seed fractions of common fruits as determined by FRAP assay. Nutrition Research 2003, 23:1719-1726.
49. Hajimahmoodi M., Oveisi M.R., Sadeghi N., Jannat B., Hadjibabaie M., Farahani E., Akrami M.R., Namdar R. Antioxidant properties of peel and pulp hydro extract in ten Persian pomegranate cultivars. Pakistan Journal of Biological Sciences 2008, 11:1600-1604.
50. Negi P.S., Jayaprakasha G.K., Jena B.S. Antioxidant and antimutagenic activities of pomegranate peel extracts. Food Chemistry 2003, 80:393-397.
51. Chidambara Murthy K.N., Jayaprakasha G.K., Singh R.P. Studies on antioxidant activity of pomegranate (Punica granatum) peel extract using in vivo models. Journal of Agricultural and Food Chemistry 2002, 50:4791-4795.
52. Toklu H.Z., Dumlu M.U., Sehirli O., Ercan F., Gedik N., Gokmen V., Sener G. Pomegranate peel extract prevents liver fibrosis in biliary-obstructed rats. Journal of Pharmacy and Pharmacology 2007, 59:1287-1295.
53. Seeram N.P., Aviram M., Zhang Y., Henning S.M., Feng L., Dreher M., Heber D. Comparison of antioxidant potency of commonly consumed polyphenol-rich beverages in the United States. Journal of Agricultural and Food Chemistry 2008, 56:1415-1422.
54. Alper N., Bahceci K.S., Acar J. Influence of processing and pasteurization on color values and total phenolic compounds of pomegranate juice. Journal of Food Processing and Preservation 2005, 29:357-368.
55. Faria A., Monteiro R., Mateus N., Azevedo I., Calhau C. Effect of pomegranate (Punica granatum) juice intake on hepatic oxidative stress. European Journal of Nutrition 2007, 46:271-278.
56. Mertens-Talcott S.U., Jilma-Stohlawetz P., Rios J., Hingorani L., Derendorf H. Absorption, metabolism, and antioxidant effects of pomegranate (Punica granatum L.) polyphenols after ingestion of a standardized extract in healthy human volunteers. Journal of Agricultural and Food Chemistry 2006, 54:8956-8961.
57. Rosenblat M., Hayek T., Aviram M. Anti-oxidative effects of pomegranate juice (PJ) consumption by diabetic patients on serum and on macrophages. Atherosclerosis 2006, 187:363-371.
58. Aviram M., Rosenblat M., Gaitini D., Nitecki S., Hoffman A., Dornfeld L., Volkova N., Presser D., Attias J., Liker H., Hayek T. Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation. Clinical Nutrition 2004, 23:423-433.
59. Lin C.C., Hsu Y.F., Lin T.C., Hsu H.Y. Antioxidant and hepatoprotective effects of punicalagin and punicalin on acetaminophen-induced liver damage in rats. Phytotherapy Research 2001, 15:206-212.
60. Lin C.C., Hsu Y.F., Lin T.C. Effects of punicalagin and punicalin on carrageenan-induced inflammation in rats. American Journal of Chinese Medicine 1999, 27:371-376.
61. Lin C.C., Hsu Y.F., Lin T.C., Hsu F.L., Hsu H.Y. Antioxidant and hepatoprotective activity of punicalagin and punicalin on carbon tetrachloride-induced liver damage in rats. Journal of Pharmacy and Pharmacology 1998, 50:789-794.
62. Cerda B., Periago P., Espin J.C., Tomas-Barberan F.A. Identification of urolithin A as a metabolite produced by human colon microflora from ellagic acid and related compounds. Journal of Agricultural and Food Chemistry 2005, 53:5571-5576.
63. Seeram N.P., Henning S.M., Zhang Y., Suchard M., Li Z., Heber D. Pomegranate juice ellagitannin metabolites are present in human plasma and some persist in urine for up to 48 hours. Journal of Nutrition 2006, 136:2481-2485.
64. Seeram, N. P., Zhang, Y. J., Sartipipour, M., Henning, S. M., Lee, R. P., Harris, D. M., Moro, A., and Heber, D. (2007). Pharmacokinetics and tissue disposition of urolithin A, an ellagitannin-derived metabolite, in mice. Faseb Journal, 21, 842.10.
65. Seeram N.P., Aronson W.J., Zhang Y., Henning S.M., Moro A., Lee R.P., Sartippour M., Harris D.M., Rettig M., Suchard M.A., Pantuck A.J., Belldegrun A., Heber D. Pomegranate ellagitannin-derived metabolites inhibit prostate cancer growth and localize to the mouse prostate gland. Journal of Agricultural and Food Chemistry 2007, 55:7732-7737.
66. Faria A., Monteiro R., Azevedo I., Calhau C. Pomegranate juice effects on cytochrome p450s expression: In vivo studies. Journal of Medicinal Food 2007, 10:643-649.
67. Patterson L.H., Murray G.I. Tumour cytochrome p450 and drug activation. Current Pharmaceutical Design 2002, 8:1335-1347.
68. Mehta R., Lansky E.P. Breast cancer chemopreventive properties of pomegranate (Punica granatum) fruit extracts in a mouse mammary organ culture. European Journal of Cancer Prevention 2004, 13:345-348.
69. Shukla S., Gupta S. Molecular mechanisms for apigenin-induced cell-cycle arrest and apoptosis of hormone refractory human prostate carcinoma DU145 cells. Molecular Carcinogenesis 2004, 39:114-126.
70. Pastorekova S., Parkkila S., Pastorek J., Supuran C.T. Carbonic anhydrases: Current state of the art, therapeutic applications and future prospects. Journal of Enzyme Inhibition and Medicinal Chemistry 2004, 19:199-229.
71. Satomi H., Umemura K., Ueno A., Hatano T., Okuda T., Noro T. Carbonic anhydrase inhibitors from the pericarps of Punica granatum L. Biological & Pharmaceutical Bulletin 1993, 16:787-790.
72. Afaq F., Malik A., Syed D., Maes D., Matsui M.S., Mukhtar H. Pomegranate fruit extract modulates UV-B-mediated phosphorylation of mitogen-activated protein kinases and activation of nuclear factor kappa B in normal human epidermal keratinocytes paragraph sign. Photochemistry and Photobiology 2005, 81:38-45.
73. Hora J.J., Maydew E.R., Lansky E.P., Dwivedi C. Chemopreventive effects of pomegranate seed oil on skin tumor development in cd1 mice. Journal of Medicinal Food 2003, 6:157-161.
74. Kim N.D., Mehta R., Yu W., Neeman I., Livney T., Amichay A., Poirier D., Nicholls P., Kirby A., Jiang W., Mansel R., Ramachandran C., Rabi T., Kaplan B., Lansky E. Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer. Breast Cancer Research and Treatment 2002, 71:203-217.
75. Zhu Y.S., Cai L.Q., Huang Y., Fish J., Wang L., Zhang Z.K., Imperato-McGinley J.L. Receptor isoform and ligand-specific modulation of dihydrotestosterone-induced prostate specific antigen gene expression and prostate tumor cell growth by estrogens. Journal of Andrology 2005, 26:500-508. discussion 509-510.
76. Syed D.N., Afaq F., Mukhtar H. Pomegranate derived products for cancer chemoprevention. Seminars in Cancer Biology 2007, 17:377-385.
77. Toi M., Bando H., Ramachandran C., Melnick S.J., Imai A., Fife R.S., Carr R.E., Oikawa T., Lansky E.P. Preliminary studies on the anti-angiogenic potential of pomegranate fractions in vitro and in vivo. Angiogenesis 2003, 6:121-128.
78. Albrecht M., Jiang W., Kumi-Diaka J., Lansky E.P., Gommersall L.M., Patel A., Mansel R.E., Neeman I., Geldof A.A., Campbell M.J. Pomegranate extracts potently suppress proliferation, xenograft growth, and invasion of human prostate cancer cells. Journal of Medicinal Food 2004, 7:274-283.
79. Larrosa M., Tomas-Barberan F.A., Espin J.C. The dietary hydrolysable tannin punicalagin releases ellagic acid that induces apoptosis in human colon adenocarcinoma caco-2 cells by using the mitochondrial pathway. Journal of Nutritional Biochemistry 2006, 17:611-625.
80. Shukla M., Gupta K., Rasheed Z., Khan K.A., Haqqi T.M. Bioavailable constituents/metabolites of pomegranate (Punica granatum L) preferentially inhibit COX2 activity ex vivo and il-1beta-induced pge2 production in human chondrocytes in vitro. Journal of Inflammation (London, England) 2008, 5:9.
81. Okamoto T., Akuta T., Tamura F., van Der Vliet A., Akaike T. Molecular mechanism for activation and regulation of matrix metalloproteinases during bacterial infections and respiratory inflammation. Biological Chemistry 2004, 385:997-1006.
82. Heber D. Multitargeted therapy of cancer by ellagitannins. Cancer Letters 2008, 269:262-268.
83. Conner E.M., Grisham M.B. Inflammation, free radicals, and antioxidants. Nutrition 1996, 12:274-277.
84. Sparreboom A., Cox M.C., Acharya M.R., Figg W.D. Herbal remedies in the United States: Potential adverse interactions with anticancer agents. Journal of Clinical Oncology 2004, 22:2489-2503.
85. Hidaka M., Fujita K., Ogikubo T., Yamasaki K., Iwakiri T., Okumura M., Kodama H., Arimori K. Potent inhibition by star fruit of human cytochrome P450 3A (CYP3A) activity. Drug Metabolism and Disposition 2004, 32:581-583.
86. Obach R.S. Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, a herbal preparation used in the treatment of depression. Journal of Pharmacology and Experimental Therapeutics 2000, 294:88-95.
87. Wang Z., Gorski J.C., Hamman M.A., Huang S.M., Lesko L.J., Hall S.D. The effects of St John's Wort (Hypericum perforatum) on human cytochrome P450 activity. Clinical Pharmacology and Therapeutics 2001, 70:317-326.
88. Hidaka M., Okumura M., Fujita K., Ogikubo T., Yamasaki K., Iwakiri T., Setoguchi N., Arimori K. Effects of pomegranate juice on human cytochrome P450 3A (CYP3A) and carbamazepine pharmacokinetics in rats. Drug Metabolism and Disposition 2005, 33:644-648.
89. Nagata M., Hidaka M., Sekiya H., Kawano Y., Yamasaki K., Okumura M., Arimori K. Effects of pomegranate juice on human cytochrome P450 2C9 and tolbutamide pharmacokinetics in rats. Drug Metabolism and Disposition 2007, 35:302-305.
90. Kim H., Yoon Y.J., Shon J.H., Cha I.J., Shin J.G., Liu K.H. Inhibitory effects of fruit juices on CYP3A activity. Drug Metabolism and Disposition 2006, 34:521-523.
91. Farkas D., Oleson L.E., Zhao Y., Harmatz J.S., Zinny M.A., Court M.H., Greenblatt D.J. Pomegranate juice does not impair clearance of oral or intravenous midazolam, a probe for cytochrome P450-3A activity: Comparison with grapefruit juice. Journal of Clinical Pharmacology 2007, 47:286-294.
92. Cerda B., Ceron J.J., Tomas-Barberan F.A., Espin J.C. Repeated oral administration of high doses of the pomegranate ellagitannin punicalagin to rats for 37 days is not toxic. Journal of Agricultural and Food Chemistry 2003, 51:3493-3501.
93. Patel C., Dadhaniya P., Hingorani L., Soni M.G. Safety assessment of pomegranate fruit extract: Acute and subchronic toxicity studies. Food and Chemical Toxicology 2008, 46:2728-2735.
94. Heber D., Seeram N.P., Wyatt H., Henning S.M., Zhang Y., Ogden L.G., Dreher M., Hill J.O. Safety and antioxidant activity of a pomegranate ellagitannin-enriched polyphenol dietary supplement in overweight individuals with increased waist size. Journal of Agricultural and Food Chemistry 2007, 55:10050-10054.